Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 03 02 2022
revised: 28 02 2022
accepted: 02 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Sodium glucose transporter type 2 (SGLT2) molecules are found in proximal tubules of the kidney, and perhaps in the brain or intestine, but rarely in any other tissue. However, their inhibitors, intended to improve diabetes compensation, have many more beneficial effects. They improve kidney and cardiovascular outcomes and decrease mortality. These benefits are not limited to diabetics but were also found in non-diabetic individuals. The pathophysiological pathways underlying the treatment success have been investigated in both clinical and experimental studies. There have been numerous excellent reviews, but these were mostly restricted to limited aspects of the knowledge. The aim of this review is to summarize the known experimental and clinical evidence of SGLT2 inhibitors' effects on individual organs (kidney, heart, liver, etc.), as well as the systemic changes that lead to an improvement in clinical outcomes.

Identifiants

pubmed: 35269954
pii: ijms23052812
doi: 10.3390/ijms23052812
pmc: PMC8911473
pii:
doi:

Substances chimiques

Sodium-Glucose Transporter 2 0
Sodium-Glucose Transporter 2 Inhibitors 0
Sodium 9NEZ333N27
Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : General University Hospital in Prague
ID : Project RVO-VFN64165

Références

J Mol Cell Cardiol. 2022 Feb;163:118-132
pubmed: 34737121
Int J Mol Sci. 2021 Sep 30;22(19):
pubmed: 34638943
Eur Heart J. 2021 Dec 21;42(48):4891-4901
pubmed: 34423370
Diabetes Metab Syndr Obes. 2020 Jan 21;13:161-174
pubmed: 32021362
Diabetes Obes Metab. 2020 Jul;22(7):1207-1214
pubmed: 32030863
Endocr Res. 2020 Feb - May;45(2):147-161
pubmed: 31955626
Lancet. 2014 Jun 7;383(9933):2008-17
pubmed: 24910232
Diabetes. 2016 May;65(5):1190-5
pubmed: 26861783
Diabetes Metab Syndr Obes. 2020 Aug 05;13:2781-2799
pubmed: 32848437
Lancet Diabetes Endocrinol. 2016 Oct;4(10):814
pubmed: 27663956
Diabetologia. 2020 Jun;63(6):1128-1140
pubmed: 32236732
Lancet. 2019 Jan 5;393(10166):31-39
pubmed: 30424892
Diabetes Obes Metab. 2015 Dec;17(12):1180-93
pubmed: 26343814
Cardiovasc Diabetol. 2017 Mar 3;16(1):32
pubmed: 28253918
Ther Adv Chronic Dis. 2020 Sep 26;11:2040622320961599
pubmed: 33062238
Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):725-729
pubmed: 27730088
Endocr J. 2021 Mar 28;68(3):329-343
pubmed: 33390421
Diabetes Obes Metab. 2020 Oct;22(10):1753-1766
pubmed: 32436638
Sci Rep. 2019 Nov 29;9(1):17937
pubmed: 31784656
Diabetes Obes Metab. 2014 Feb;16(2):159-69
pubmed: 23906445
World J Diabetes. 2021 May 15;12(5):514-523
pubmed: 33995841
N Engl J Med. 2016 Nov 3;375(18):1801-2
pubmed: 27806236
Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1433-1444
pubmed: 32994159
Front Cardiovasc Med. 2020 Jan 08;6:186
pubmed: 31970162
Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1705-1714
pubmed: 33214158
Diabetes Obes Metab. 2015 Oct;17(10):936-48
pubmed: 26040302
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Life Sci. 2020 Jan 1;240:117090
pubmed: 31765648
Cardiovasc Diabetol. 2017 Jan 13;16(1):8
pubmed: 28086872
Diabetes Care. 2018 Dec;41(12):2669-2701
pubmed: 30291106
J Clin Endocrinol Metab. 2012 Mar;97(3):1020-31
pubmed: 22238392
Adv Ther. 2017 Feb;34(2):436-451
pubmed: 27981497
Metabolism. 2018 Aug;85:32-37
pubmed: 29452178
Ann Palliat Med. 2021 Jun;10(6):6467-6481
pubmed: 34118855
Diabetes Obes Metab. 2021 Jun;23(6):1426-1430
pubmed: 33606921
J Clin Invest. 2014 Feb;124(2):499-508
pubmed: 24463454
Br J Pharmacol. 2021 Apr;178(8):1756-1771
pubmed: 33480065
JACC Heart Fail. 2021 Aug;9(8):578-589
pubmed: 34325888
J Am Soc Nephrol. 2021 Sep;32(9):2352-2361
pubmed: 34272327
J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639
pubmed: 29540325
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31837264
Mediators Inflamm. 2016;2016:6305735
pubmed: 28104929
Eur Heart J. 2021 Mar 31;42(13):1216-1227
pubmed: 33792669
Diabetologia. 2016 Sep;59(9):1860-70
pubmed: 27316632
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
J Am Coll Cardiol. 2020 Nov 3;76(18):2076-2085
pubmed: 33121714
Cardiovasc Diabetol. 2017 Jul 6;16(1):84
pubmed: 28683796
Int J Mol Sci. 2019 Dec 26;21(1):
pubmed: 31888083
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F173-F185
pubmed: 30427222
Diabetes Obes Metab. 2015 Apr;17(4):426-9
pubmed: 25600248
JAMA. 2020 Apr 14;323(14):1353-1368
pubmed: 32219386
Br J Pharmacol. 2010 May;160(1):77-87
pubmed: 20331602
Diabetes Obes Metab. 2018 Nov;20(11):2532-2540
pubmed: 29888547
Clin Sci (Lond). 2020 Dec 11;134(23):3107-3118
pubmed: 33205810
Diabetes. 2003 Mar;52(3):741-50
pubmed: 12606516
Lancet Diabetes Endocrinol. 2021 Feb;9(2):106-116
pubmed: 33357505
Diabetes Care. 2013 Aug;36(8):2154-61
pubmed: 23412078
Lancet Diabetes Endocrinol. 2016 Mar;4(3):211-220
pubmed: 26620248
Front Cardiovasc Med. 2021 Jun 30;8:690529
pubmed: 34277737
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Lancet Diabetes Endocrinol. 2019 Aug;7(8):606-617
pubmed: 31196815
Eur J Heart Fail. 2020 Apr;22(4):713-722
pubmed: 31912605
Circulation. 2018 Jul 31;138(5):458-468
pubmed: 29526832
Diabetes Metab. 2016 Feb;42(1):25-32
pubmed: 26575250
Vasc Med. 2021 Apr;26(2):131-138
pubmed: 33095685
Front Endocrinol (Lausanne). 2021 Oct 14;12:735824
pubmed: 34721294
Cardiovasc Diabetol. 2021 Feb 11;20(1):39
pubmed: 33573667
JACC Heart Fail. 2018 Jun;6(6):489-498
pubmed: 29655829
Ther Adv Cardiovasc Dis. 2020 Jan-Dec;14:1753944720939383
pubmed: 32715944
Cardiovasc Diabetol. 2018 Jan 4;17(1):5
pubmed: 29301520
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
JCI Insight. 2020 Mar 26;5(6):
pubmed: 32134397
Acta Diabetol. 2020 Nov;57(11):1367-1373
pubmed: 32617672
J Fr Ophtalmol. 2021 Oct;44(8):1159-1167
pubmed: 34244004
Int J Mol Sci. 2021 Apr 22;22(9):
pubmed: 33922132
Lancet Diabetes Endocrinol. 2021 Nov;9(11):755-766
pubmed: 34619106
Circulation. 2020 Jan 14;141(2):100-111
pubmed: 31736328
Compr Physiol. 2021 Dec 29;12(1):2995-3044
pubmed: 34964123
Diabetes Care. 2018 Aug;41(8):1801-1808
pubmed: 29895557
J Clin Invest. 2014 Feb;124(2):509-14
pubmed: 24463448
J Am Heart Assoc. 2020 Jul 7;9(13):e016173
pubmed: 32567439
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F1017-F1029
pubmed: 32116017
Cardiovasc Diabetol. 2020 Jun 15;19(1):91
pubmed: 32539724
Diabetes Obes Metab. 2014 May;16(5):467-77
pubmed: 24528605
Int J Mol Sci. 2021 Oct 26;22(21):
pubmed: 34768942
Diabetes Care. 2012 Jul;35(7):1473-8
pubmed: 22446170
Diabetes Obes Metab. 2014 Feb;16(2):124-36
pubmed: 23911013
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):903-913
pubmed: 34555346
J Am Heart Assoc. 2021 Aug 3;10(15):e020418
pubmed: 34278803
Diabetes Metab Syndr. 2018 Jan - Mar;12(1):59-63
pubmed: 28826578
J Diabetes Complications. 2019 Oct;33(10):107402
pubmed: 31375422
Cardiovasc Diabetol. 2017 Feb 27;16(1):29
pubmed: 28241822
Am J Physiol Cell Physiol. 2012 Apr 15;302(8):C1174-88
pubmed: 22262063
Acta Diabetol. 2018 Nov;55(11):1105-1111
pubmed: 30155580
Physiol Behav. 2005 Dec 15;86(5):640-5
pubmed: 16260008
J Biol Chem. 2020 Oct 16;295(42):14379-14390
pubmed: 32796035
Nefrologia (Engl Ed). 2021 Aug 24;:
pubmed: 34452776
Nat Commun. 2020 May 1;11(1):2127
pubmed: 32358544
Metabolism. 2020 Dec;113:154405
pubmed: 33069809
Can J Physiol Pharmacol. 2018 Nov;96(11):1184-1187
pubmed: 30265814
Sci Rep. 2020 Dec 28;10(1):22396
pubmed: 33372185
J Am Geriatr Soc. 2016 Nov;64(11):2302-2306
pubmed: 27640987
Endocrinol Diabetes Nutr (Engl Ed). 2022 Jan;69(1):52-62
pubmed: 35232560
J Hypertens. 2018 Dec;36(12):2284-2309
pubmed: 30379783
J Am Soc Nephrol. 2017 Jan;28(1):368-375
pubmed: 27539604
Metabolism. 2020 Oct;111:154324
pubmed: 32712220
Curr Opin Pharmacol. 2020 Oct;54:11-17
pubmed: 32682281
Int J Mol Sci. 2021 Dec 31;23(1):
pubmed: 35008865
Diabetes Obes Metab. 2022 Feb;24(2):228-238
pubmed: 34617381
Am J Physiol Endocrinol Metab. 2013 Jan 15;304(2):E117-30
pubmed: 23149623
Circulation. 2019 Nov 19;140(21):1693-1702
pubmed: 31434508
Kidney Int. 2020 Jan;97(1):202-212
pubmed: 31791665
Diabetes Obes Metab. 2015 Nov;17(11):1075-84
pubmed: 26212528
Curr Med Res Opin. 2014 Jun;30(6):1109-19
pubmed: 24517339
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Biochem Biophys Res Commun. 2017 Nov 4;493(1):40-45
pubmed: 28928093
Am J Physiol Renal Physiol. 2015 Mar 1;308(5):F400-10
pubmed: 25537743
Nat Med. 2021 Nov;27(11):1954-1960
pubmed: 34711976
Int J Mol Sci. 2022 Jan 25;23(3):
pubmed: 35163285
Biopharm Drug Dispos. 2014 Oct;35(7):391-404
pubmed: 25044127
Diabetes Obes Metab. 2021 Dec;23(12):2814-2818
pubmed: 34378852
J Am Heart Assoc. 2021 Jul 6;10(13):e021949
pubmed: 34169746
Pharmacology. 2022;107(3-4):123-130
pubmed: 34942623
J Nephrol. 2016 Jun;29(3):391-400
pubmed: 26894924
J Hypertens. 2020 Sep;38(9):1811-1819
pubmed: 32516291
Cardiovasc Diabetol. 2021 Jan 7;20(1):6
pubmed: 33413355
Hypertension. 2016 Dec;68(6):1355-1364
pubmed: 27977392
Diabetes Care. 2019 May;42(5):931-937
pubmed: 30885955
J Am Soc Nephrol. 2011 Jan;22(1):113-23
pubmed: 21209254
Curr Opin Pharmacol. 2020 Oct;54:82-90
pubmed: 32980777
Int J Mol Sci. 2020 Apr 23;21(8):
pubmed: 32340263
JACC Cardiovasc Imaging. 2021 Jun;14(6):1164-1173
pubmed: 33454272
Am J Hypertens. 2013 May;26(5):665-72
pubmed: 23391621
J Am Coll Cardiol. 2021 Jan 26;77(3):243-255
pubmed: 33197559
Diabetes Metab Res Rev. 2021 Sep;37(6):e3413
pubmed: 33010191
Front Endocrinol (Lausanne). 2020 Mar 17;11:111
pubmed: 32256445
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F824-F833
pubmed: 29167170
Eur J Heart Fail. 2021 Jan;23(1):68-78
pubmed: 33251643
Am J Nephrol. 2020;51(2):119-129
pubmed: 31910407
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
J Am Heart Assoc. 2017 May 25;6(6):
pubmed: 28546454
Diabetes Metab. 2020 Apr;46(2):164-168
pubmed: 31816432
J Clin Pharmacol. 2022 Mar;62(3):366-375
pubmed: 34545949
J Diabetes Complications. 2020 Nov;34(11):107704
pubmed: 32888788
Cardiovasc Diabetol. 2017 Oct 23;16(1):138
pubmed: 29061124
PLoS One. 2011;6(8):e23646
pubmed: 21901125
Diabetes Obes Metab. 2012 Nov;14(11):990-9
pubmed: 22651373
Kidney Int. 2021 Mar;99(3S):S1-S87
pubmed: 33637192
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):66-73
pubmed: 30559106
Pharmacol Res. 2020 Oct;160:105068
pubmed: 32652200
Circulation. 2014 Feb 4;129(5):587-97
pubmed: 24334175
J Am Heart Assoc. 2017 May 18;6(5):
pubmed: 28522675
J Am Soc Nephrol. 2020 May;31(5):1128-1139
pubmed: 32354987
Diabetes Obes Metab. 2017 Nov;19(11):1620-1624
pubmed: 28387058
Circulation. 2019 Oct 29;140(18):1463-1476
pubmed: 31524498
Europace. 2022 Jan 26;:
pubmed: 35080624

Auteurs

Věra Čertíková Chábová (V)

Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 12800 Prague 2, Czech Republic.

Oskar Zakiyanov (O)

Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 12800 Prague 2, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH